Advanced Drug Delivery Reviews

Papers
(The H4-Index of Advanced Drug Delivery Reviews is 87. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology644
Editorial board members598
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies358
Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity283
MIDD in Japan– Implementations, challenges and opportunities279
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies278
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound275
Recent advances in endocrine organoids for therapeutic application238
Drug delivery for metabolism targeted cancer immunotherapy235
Deciphering albumin-directed drug delivery by imaging228
Bacterially mediated drug delivery and therapeutics: Strategies and advancements226
Agony of choice: How anesthetics affect the composition and function of extracellular vesicles220
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses199
Therapeutic and delivery strategies of phytoconstituents for renal fibrosis198
Penetration and translocation of functional inorganic nanomaterials into biological barriers184
Liposomal formulations for treating lysosomal storage disorders180
Nanoparticle-neutrophils interactions for autoimmune regulation179
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles171
Recent applications of electrical, centrifugal, and pressurised emerging technologies for fibrous structure engineering in drug delivery, regenerative medicine and theranostics163
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders153
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond150
Models to study basic and applied aspects of lysosomal storage disorders149
Tools for computational design and high-throughput screening of therapeutic enzymes149
Long-acting inhaled medicines: Present and future144
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine139
MicroRNAs and their delivery in diabetic fibrosis137
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity137
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria137
Nanovaccines with cell-derived components for cancer immunotherapy136
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art136
Biopharmaceutical drug delivery and phototherapy using protein crystals130
Editorial/Preface129
Ultrasonic particles: An approach for targeted gene delivery128
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)128
Targeting microbiome, drug metabolism, and drug delivery in oncology128
Phytonanomaterials as therapeutic agents and drug delivery carriers126
Editorial Board125
Novel strategies for modulating the gut microbiome for cancer therapy123
In vitro-in vivo correlation of cascade impactor data for orally inhaled pharmaceutical aerosols123
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics123
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders122
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly121
Synthetic biology-guided design and biosynthesis of protein polymers for delivery121
Activatable dual-functional molecular agents for imaging-guided cancer therapy121
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease120
Physical methods for enhancing drug absorption from the gastrointestinal tract119
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications118
Solid implantable devices for sustained drug delivery117
Activatable fluorescent probes for real-time imaging-guided tumor therapy116
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer116
Drug delivery using gold nanoparticles115
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers112
Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems112
In situ cellular hitchhiking of nanoparticles for drug delivery112
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches111
Role of extracellular vesicles in liver diseases and their therapeutic potential111
Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases111
Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery110
3D printing of drug delivery systems enhanced with micro/nano-technology109
Strategies to develop polymeric microneedles for controlled drug release109
Model-informed precision dosing: State of the art and future perspectives107
Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control107
Lysosomal therapies and drug delivery strategies: An overview107
Drug delivery strategies for management of women’s health issues in the upper genital tract106
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective106
Novel drug delivery systems for the management of dry eye105
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers102
High-throughput proteomics and AI for cancer biomarker discovery102
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer102
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system101
Technological and translational challenges for extracellular vesicle in therapy and diagnosis100
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors100
Soft nano and microstructures for the photomodulation of cellular signaling and behavior98
In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunities97
The extracellular matrix of hematopoietic stem cell niches96
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases95
Modular design principle based on compartmental drug delivery systems95
Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos94
Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy93
Tumour extravasation of nanomedicine: The EPR and alternative pathways92
Nanobodies: Robust miniprotein binders in biomedicine92
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities90
Engineering complexity in human tissue models of cancer89
Unignored intracellular journey and biomedical applications of extracellular vesicles89
Fit and forget: The future of dental implant therapy via nanotechnology88
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives87
Editorial board members87
0.031558990478516